Gilead Sciences Reports WHO Solidarity Trial Data for Remdesivir in COVID-19

Gilead Sciences today presented data from the WHO Solidarity trial evaluating remdesivir in hospitalized patients with COVID-19 across multiple countries. The trial provided important insights into the effectiveness of remdesivir in different patient populations and disease severity levels, contributing to global understanding of COVID-19 treatment options.